BioPharm International is the #1 magazine devoted to the science, strategies and business trends shaping the global landscape for biotherapeutics. BioPharm's focus on applied technologies utilized in biopharmaceutical development and its focus on the business forces driving the industry's growth has attracted a BPA-qualified, global audience of 29,200.

BioProcess International provides the biotechnology industry with monthly, peer-reviewed information necessary to successfully drive products through the biopharmaceutical, biovaccine and biodiagnostic development and manufacture process. BPI's circulation consists of 30,000 mid-to-upper managers working in all phases of the biotherapeutic development and manufacturing process in the United States, Europe and Canada.

European Biotechnology Science & Industry News
The 15,000 circulated copies are directed at the decision-makers in science and industry of the unified Europe. With the European Biotechnology News magazine you can address a competent and specialized readership in all 25 EU-countries, in Switzerland and Norway, predominantly in the major biotech clusters, in renowned European research institutions, as well as the current members of 20 scientific and corporate associations and readers in the biotechnology and Life Sciences industry sector. Topical industry news, background information on the current political issues from Brussels, country specials as well as scientific and technical highlights provide an attractive source of information.

The Williamsburg BioProcessing Foundation (WilBio) was established in 1994 to advance the development of safe and effective biological products by providing venues for the exchange of bioprocess technology. In 2002, WilBio launched the BioProcessing Journal? to enhance the exchange of bioprocess technology. Now in our 11th year, we have grown from six to 13 conference and from one to three publications.